These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

641 related items for PubMed ID: 11005642

  • 21. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II).
    Kamijyo Y, Hirota-Kawadobora M, Yamauchi K, Terasawa F, Honda T, Ikeya M, Okumura N.
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):726-32. PubMed ID: 19809304
    [Abstract] [Full Text] [Related]

  • 22. Influence of homocysteine on fibrin network lysis.
    Lauricella AM, Quintana I, Castañon M, Sassetti B, Kordich L.
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):181-6. PubMed ID: 16575255
    [Abstract] [Full Text] [Related]

  • 23. Transport phenomena and clot dissolving therapy: an experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis.
    Wu JH, Siddiqui K, Diamond SL.
    Thromb Haemost; 1994 Jul; 72(1):105-12. PubMed ID: 7974357
    [Abstract] [Full Text] [Related]

  • 24. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.
    Schaefer AV, Leslie BA, Rischke JA, Stafford AR, Fredenburgh JC, Weitz JI.
    Biochemistry; 2006 Apr 04; 45(13):4257-65. PubMed ID: 16566600
    [Abstract] [Full Text] [Related]

  • 25. Depletion of plasminogen in vitro or during thrombolytic therapy limits fibrinolytic potential.
    Onundarson PT, Francis CW, Marder VJ.
    J Lab Clin Med; 1992 Jul 04; 120(1):120-8. PubMed ID: 1613318
    [Abstract] [Full Text] [Related]

  • 26. A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis.
    Jones AJ, Meunier AM.
    Thromb Haemost; 1990 Nov 30; 64(3):455-63. PubMed ID: 2128976
    [Abstract] [Full Text] [Related]

  • 27. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
    Sauls DL, Lockhart E, Warren ME, Lenkowski A, Wilhelm SE, Hoffman M.
    Biochemistry; 2006 Feb 28; 45(8):2480-7. PubMed ID: 16489740
    [Abstract] [Full Text] [Related]

  • 28. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH, Rijken DC.
    Thromb Haemost; 2004 Mar 28; 91(3):473-9. PubMed ID: 14983222
    [Abstract] [Full Text] [Related]

  • 29. Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis.
    Parise P, Morini M, Agnelli G, Ascani A, Nenci GG.
    Blood Coagul Fibrinolysis; 1993 Oct 28; 4(5):721-7. PubMed ID: 8292721
    [Abstract] [Full Text] [Related]

  • 30. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
    Pannell R, Black J, Gurewich V.
    J Clin Invest; 1988 Mar 28; 81(3):853-9. PubMed ID: 2963831
    [Abstract] [Full Text] [Related]

  • 31. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
    Jankun J, Aleem AM, Selman SH, Skrzypczak-Jankun E, Lysiak-Szydlowska W, Grafos N, Fryer HJ, Greenfield RS.
    Int J Mol Med; 2007 Nov 28; 20(5):683-7. PubMed ID: 17912461
    [Abstract] [Full Text] [Related]

  • 32. The biochemical and physical process of fibrinolysis and effects of clot structure and stability on the lysis rate.
    Weisel JW, Litvinov RI.
    Cardiovasc Hematol Agents Med Chem; 2008 Jul 28; 6(3):161-80. PubMed ID: 18673231
    [Abstract] [Full Text] [Related]

  • 33. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M, D'Aprile AM, Italia A, Gresele P, Morser J, Semeraro N.
    Thromb Haemost; 2001 Apr 28; 85(4):661-6. PubMed ID: 11341502
    [Abstract] [Full Text] [Related]

  • 34. Clot penetration and retention by plasminogen activators promote fibrinolysis.
    Marcos-Contreras OA, Ganguly K, Yamamoto A, Shlansky-Goldberg R, Cines DB, Muzykantov VR, Murciano JC.
    Biochem Pharmacol; 2013 Jan 15; 85(2):216-22. PubMed ID: 23098998
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood.
    Haskel EJ, Eisenberg PR, Abendschein DR.
    Blood Coagul Fibrinolysis; 1993 Feb 15; 4(1):7-13. PubMed ID: 8457655
    [Abstract] [Full Text] [Related]

  • 36. In vitro studies on the fibrinolytic, thrombolytic and fibrinogenolytic properties of a tissue plasminogen activator from guinea pig keratocytes.
    Electricwala A, Ling RJ, Sutton PM, Griffiths B, Riley PA, Atkinson T.
    Thromb Haemost; 1985 Apr 22; 53(2):200-3. PubMed ID: 4040659
    [Abstract] [Full Text] [Related]

  • 37. Tissue-type plasminogen activator increases the binding of glu-plasminogen to clots.
    Tran-Thang C, Kruithof EK, Bachmann F.
    J Clin Invest; 1984 Dec 22; 74(6):2009-16. PubMed ID: 6210307
    [Abstract] [Full Text] [Related]

  • 38. Activation of the fibrinolytic system.
    Robison AK, Collen D.
    Cardiol Clin; 1987 Feb 22; 5(1):13-9. PubMed ID: 3103919
    [Abstract] [Full Text] [Related]

  • 39. The influence of transport parameters and enzyme kinetics of the fibrinolytic system on thrombolysis: mathematical modelling of two idealised cases.
    Zidansek A, Blinc A.
    Thromb Haemost; 1991 May 06; 65(5):553-9. PubMed ID: 1831302
    [Abstract] [Full Text] [Related]

  • 40. MASP-1 of the complement system alters fibrinolytic behaviour of blood clots.
    Jenny L, Noser D, Larsen JB, Dobó J, Gál P, Pál G, Schroeder V.
    Mol Immunol; 2019 Oct 06; 114():1-9. PubMed ID: 31325724
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.